Therapeutic Polycomb Targeting in Human Cancer

E-ISSN： 2210-2973|2|1|22-29

ISSN： 2210-2965

Source： Recent Patents on Regenerative Medicine, Vol.2, Iss.1, 2012-01, pp. : 22-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Strategies for Targeting BRAF in Human Cancer

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 121-134

Bentham Science Publishers

Access to resources Recommend Favorite

The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 5, 2015-05 ,pp. : 458-464

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic Targeting of microRNAs in Cancer: Future Perspectives

DRUG DEVELOPMENT RESEARCH, Vol. 76, Iss. 7, 2015-11 ,pp. : 382-388

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic Targeting of Signal Transduction Pathways and Proteins in Breast Cancer

By Hynes Nancy Gullick William

Journal of Mammary Gland Biology and Neoplasia, Vol. 11, Iss. 1, 2006-01 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite

Targeting epithelial-mesenchymal transition: therapeutic reversal of the cancer stem cell phenotype

By Fruehauf John P Liau Ming C

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 737-740

Future Medicine

Access to resources Recommend Favorite